LOS MITOS SOBRE LA RINITIS ALÉRGICA DIFICULTAN EL TRATAMIENTO A SUS PACIENTES

Mitos y realidades sobre la rinitis alérgica

Ayude a sus pacientes a conocer las realidades y desechar los mitos sobre el tratamiento de la rinitis alérgica de manera que puedan obtener el alivio que necesitan.

Referencias:

  1. Datos de archivo. GlaxoSmithKline. 2014.
  2. WebMD. Nasal spray: are you overdoing it? http://www.webmd.com/allergies/features/nasal-spray-are-you-overdoing-it?page=2. Acceso el 16 de octubre de 2014.
  3. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-1300.
  4. Ficha técnica FLONASE
  5. Brooks M. Allergic rhinitis a significant burden. Medscape website. http://www.medscape.com/viewarticle/739928. Publicado el 30 de marzo de 2011. Acceso el 27 de marzo de 2014.
  6. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101(5):633-637.
  7. Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011;29(4):297-306.
  8. World Allergy Organization. World Allergy Organization (WAO) White Book on Allergy. Milwaukee, WI: World Allergy Organization; 2011.
  9. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2008;63(suppl 86):8-160.
  10. Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract. 1998;47(2):118-125.
  11. Bachert C, Geveart P. Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators. Allergy. 1999;54(suppl 57):116-123.
  12. US Food and Drug Administration. FDA approves first generic version of FLONASE [news release]. Silver Spring, MD: US Food and Drug Administration; February 22, 2006. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108603.htm. Actualizado el 8 de abril de 2013. Acceso el 14 de octubre de 2014.
  13. MedlinePlus. Prednisone. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html. Acceso el 1 de abril de 2014.
  14. Bousquet J, Chanal I, Alquié MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy. 1993;48(5):327-333.]
  15. Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy. 1994;24(12):1144-1150.
  16. Benincasa C, Lloyd RS. Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest. 1994;8(4):225-233.
  17. Beggs PJ. Impacts of climate change on aeroallergens: past and future. Clin Exp Allergy. 2004;34(10):1507-1513.
  18. Yawn BP. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same? Med Gen Med. 2006;8(1):23.